Results 191 to 200 of about 49,427 (236)

Cytokine Landscapes, Immune Dysregulation, and Treatment Perspectives in Philadelphia-Negative Myeloproliferative Neoplasms: A Narrative Review. [PDF]

J Clin Med
Todor SB, Mihaila RG.
europepmc   +1 more source

Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms. [PDF]

Liver Int
Balcar L, Degenfeld-Schonburg L, Hopp C, Kramer G, Graf I, Simonis L, Sillaber C, Kalteis S, Gisslinger H, Meischl T, Stättermayer AF, Mandorfer M, Mitterbauer-Hohendanner G, Reiberger T, Trauner M, Scheiner B, Krauth MT, Semmler G.   +17 more
europepmc   +1 more source

Matrix Metalloproteinases Family Gene Polymorphisms Are Associated with Thrombosis Risk in Myeloproliferative Neoplasms. [PDF]

Int J Mol Sci
Vadeikienė R, Savukaitytė A, Laukaitienė D, Dambrauskienė R, Gerbutavičius R, Juozaitytė E, Ugenskienė R.   +6 more
europepmc   +1 more source

Myeloproliferative Neoplasms: Challenging Dogma. [PDF]

J Clin Med
Spivak JL.
europepmc   +1 more source

Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on <i>U2AF1</i>. [PDF]

J Clin Med
Park MS, Choi DH, Jang JH, Jung CW, Kim HJ, Kim HY.   +5 more
europepmc   +1 more source

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series. [PDF]

Haematologica
Yuan Y, Lane SW.
europepmc   +1 more source

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms. [PDF]

Nat Commun
Maslah N, Kaci N, Roux B, Alexe G, Marie R, Pasquer H, Verger E, De Oliveira RD, Culeux C, Mlayah B, Gauthier N, Gonzales F, Zhao LP, Ganesan S, Gou P, Ling F, Soret-Dulphy J, Parquet N, Vainchenker W, Raffoux E, Padua RA, Giraudier S, Marty C, Plo I, Lobry C, Stegmaier K, Puissant A, Kiladjian JJ, Cassinat B, Benajiba L.   +29 more
europepmc   +1 more source

CALR-mutant myeloproliferative neoplasms: insights from next-generation sequencing. [PDF]

J Appl Genet
Mroczkowska-Bękarciak A, Szeremet A, Chyrko O, Wróbel T.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pediatric Myeloproliferative Neoplasms

Clinics in Laboratory Medicine, 2021
Myeloproliferative neoplasms can present early in life and may present a diagnostic challenge. Very few studies have focused on the diagnosis, prognosis, and therapy for pediatric myeloproliferative neoplasms. This article focuses on chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, and primary myelofibrosis in children.
Farah, El-Sharkawy, Elizabeth, Margolskee   +1 more
openaire   +2 more sources

Myelodysplastic/Myeloproliferative Neoplasms

Seminars in Diagnostic Pathology, 2011
The myelodysplastic/myeloproliferative neoplasms (MDS/MPN) include clonal myeloid neoplasms that overlap the MDS and MPN categories and at the time of initial diagnosis exhibit some clinical, laboratory, or morphologic features supporting the diagnosis of myelodysplastic syndrome (MDS) and at the same time show proliferative features in keeping with ...
Elizabeth, Hyjek, James W, Vardiman
openaire   +5 more sources